Valuation: Simcere Pharmaceutical Group Limited

Market Cap 399.5Cr 3.13TCr 342.05Cr 319.14Cr 292.84Cr 550.27Cr 38TCr 561.1Cr 3.79TCr 1.48TCr 19TCr 1.5TCr 1.47TCr 63TCr P/E 2026 *
15.7x
P/E 2027 * 13.7x
Enterprise Value 380.81Cr 2.99TCr 326.05Cr 304.21Cr 279.14Cr 524.53Cr 36TCr 534.85Cr 3.61TCr 1.41TCr 18TCr 1.43TCr 1.4TCr 60TCr EV / Sales 2026 *
2.55x
EV / Sales 2027 * 2.29x
Free-Float
32.48%
Yield 2026 *
3.38%
Yield 2027 * 3.89%
1 day-0.98%
1 week-0.49%
Current month-2.19%
1 month-8.28%
3 months+13.96%
6 months-7.43%
Current year+0.92%
1 week 11.87
Extreme 11.87
12.82
1 month 11.63
Extreme 11.63
13.52
Current year 9.07
Extreme 9.07
14.28
1 year 9.07
Extreme 9.07
15.08
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
Manager TitleAgeSince
Chief Executive Officer 54 25/03/2026
Director of Finance/CFO 55 19/11/2019
Chief Tech/Sci/R&D Officer 51 01/12/2023
Director TitleAgeSince
Chairman 63 08/10/2012
Director/Board Member 55 19/11/2019
Director/Board Member 46 01/11/2019
Date Insider Type Main position Quantity % Market Cap.
13/07/26 Other

Founder

-47,000 0.0018%
13/07/26 Other

Director

-47,000 0.0018%
10/07/26 Other

Founder

-53,000 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
-0.98%-0.49%-5.40%+89.94% 399.5Cr
-0.40%-1.72%+15.65%+66.78% 4.77TCr
-3.21%+1.37%+52.36%+125.75% 4.17TCr
-0.81%-1.65%-10.47%+15.59% 1.21TCr
+0.70%-1.78%+13.11%+70.72% 1.15TCr
0.00%0.00%+30.00%+147.62% 917.64Cr
-0.39%+0.62%+19.93%+39.54% 753.96Cr
-1.35%+0.74%+47.03%-11.93% 734.5Cr
-0.83%-0.19%+19.23%+198.57% 688.04Cr
+2.65%-3.55%-31.27%+24.03% 572.33Cr
Average -0.46%-0.54%+15.02%+76.66% 1.54TCr
Weighted average by Cap. -1.05%-0.52%+23.78%+83.66%

Financials

2026 *2027 *
Net sales 149.46Cr 1.17TCr 127.97Cr 119.4Cr 109.56Cr 205.87Cr 14TCr 209.92Cr 1.42TCr 552.16Cr 7.17TCr 561.21Cr 548.99Cr 24TCr 168.83Cr 1.32TCr 144.55Cr 134.87Cr 123.76Cr 232.55Cr 16TCr 237.12Cr 1.6TCr 623.71Cr 8.1TCr 633.93Cr 620.13Cr 27TCr
Net income 25Cr 193Cr 21Cr 20Cr 18Cr 34Cr 2.35TCr 35Cr 233.21Cr 91Cr 1.18TCr 92Cr 90Cr 3.91TCr 29Cr 229.34Cr 25Cr 23Cr 21Cr 40Cr 2.8TCr 41Cr 277.12Cr 108.03Cr 1.4TCr 109.8Cr 107.41Cr 4.64TCr
Net Debt -19Cr -146.57Cr -16Cr -15Cr -14Cr -26Cr -1.79TCr -26Cr -177.11Cr -69Cr -896.16Cr -70Cr -69Cr -2.97TCr -12Cr -96Cr -10Cr -9.79Cr -8.99Cr -17Cr -1.17TCr -17Cr -116.16Cr -45Cr -587.79Cr -46Cr -45Cr -1.95TCr
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
Employees
7,038
Date Price Change Volume
21/26/21 HK$12.08 -0.98% 74,44,000
20/26/20 HK$12.20 +0.25% 1,40,74,000
19/26/19 HK$12.17 -2.41% 49,67,000
18/26/18 HK$12.47 +0.81% 40,99,000
17/26/17 HK$12.37 +1.89% 62,06,126
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
10.46CNY
Average target price
15.33CNY
Spread / Average Target
+46.50%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2096 Stock